CroatiaA recent report by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) highlights the emergence of over 50 new drugs identified in Europe during 2025 alone. The report notes a significant increase in synthetic opioids and synthetic cathinones, with particular concern raised about a new class of substances known as 'orfins,' which have been linked to more than 30 deaths across Europe. Two specific compounds, ciklorfin and spiroklorfin, have already been registered in over ten European countries and are undergoing accelerated risk assessment at the EU level. The report also cacl
Bias read (Center): The article presents factual data from an official source (European Monitoring Centre for Drugs and Drug Addiction) without overtly biased language or selective emphasis. It reports on the identification of new drugs and their associated risks but does not take a clear stance on policy, blame, or affi
Why these scores (Factual 85 · Objective 75): The article presents specific data from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) regarding new psychoactive substances identified in 2025, including synthetic opioids and 'orfins.' The information aligns with general knowledge about the increasing number of novel drugs in
